ASHTB 2011 | Tumor Board Case Discussion 3
Hematologic Oncology Update - Un pódcast de Research To Practice
Categorías:
ASHTB11 - A 57-year-old woman with relapsed CLL and a 17p deletion experiences rapid disease progression after BR and receives fludarabine/alemtuzumab followed by allogeneic stem cell transplant. Case discussion moderated by Neil Love, MD. Produced by Research To Practice.
